Chitosan-alginate multilayer beads for controlled release of ampicillin

被引:243
作者
Anal, AK [1 ]
Stevens, WF [1 ]
机构
[1] Asian Inst Technol, Bioproc Technol Program, Bangkok 12120, Thailand
关键词
chitosan; alginate; multilayer beads; ampicillin; controlled release;
D O I
10.1016/j.ijpharm.2004.11.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study is to develop multilayer beads with improved properties for controlled delivery of the antibiotic ampicillin. Ionotropic gelation was applied to prepare single and multilayer beads using various combinations of chitosan and Ca2+ as cationic components and alginate and polyphosphate as anions. Beads prepared with higher concentrations of chitosan entrapped more ampicillin. During incubation in simulated gastric fluid, the beads swelled and started to float but did not show any sign of erosion. Single layer chitosan-alginate beads released 70% of the drug within 4 h. Multilayer beads released only 20-30% in the same period of time. During subsequent incubation in simulated intestinal fluid, both single and multilayer beads continued to release drug. At least part of this release is due to disintegration of the beads. The rate of release both in gastric and intestinal fluid and the kinetics of disintegration in intestinal fluid can be controlled by changing the chitosan concentration in the coagulation fluid. The release of the drug can also be controlled by the degree of cross-linking using polyphosphate. Cross-linked multilayer beads were prepared that released only 40% of the entrapped drug during 24h. It is concluded that chitosan-alginate multilayer beads, cross-linked with polyphosphate offer an opportunity for controlled gastrointestinal passage of compounds with low molecular weight like ampicillin. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 27 条
[1]   Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein [J].
Anal, AK ;
Bhopatkar, D ;
Tokura, S ;
Tamura, H ;
Stevens, WF .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (06) :713-724
[2]   Alternative approach to the preparation of chitosan beads [J].
Aral, C ;
Akbuga, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 168 (01) :9-15
[3]  
BAILEY RW, 1970, DIAGNOSTIC MICROBIOL, P289
[4]  
Berthold A, 1996, STP PHARMA SCI, V6, P358
[5]   PSEUDOEPHEDRINE HCL MICROSPHERES FORMULATED INTO AN ORAL SUSPENSION DOSAGE FORM [J].
BODMEIER, R ;
CHEN, H ;
TYLE, P ;
JAROSZ, P .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (01) :65-77
[6]   PREPARATION AND EVALUATION OF DRUG-CONTAINING CHITOSAN BEADS [J].
BODMEIER, R ;
OH, KH ;
PRAMAR, Y .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (09) :1475-1494
[7]   STABILITY OF ALGINATE-IMMOBILIZED ALGAL CELLS [J].
DAINTY, AL ;
GOULDING, KH ;
ROBINSON, PK ;
SIMPKINS, I ;
TREVAN, MD .
BIOTECHNOLOGY AND BIOENGINEERING, 1986, 28 (02) :210-216
[8]   A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres [J].
Genta, I ;
Perugini, P ;
Conti, B ;
Pavanetto, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (02) :237-246
[9]   Chitosan microspheres prepared by spray drying [J].
He, P ;
Davis, SS ;
Illum, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (01) :53-65
[10]   GLUTARALDEHYDE CROSS-LINKED CHITOSAN MICROSPHERES AS A LONG-ACTING BIODEGRADABLE DRUG-DELIVERY VEHICLE - STUDIES ON THE IN-VITRO RELEASE OF MITOXANTRONE AND IN-VIVO DEGRADATION OF MICROSPHERES IN RAT MUSCLE [J].
JAMEELA, SR ;
JAYAKRISHNAN, A .
BIOMATERIALS, 1995, 16 (10) :769-775